Department of Cancer Biology, Loyola University Chicago, Maywood, IL 60153, USA.
Department of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Biomolecules. 2023 Mar 6;13(3):486. doi: 10.3390/biom13030486.
SELENOF, previously known as SEP15, is a selenoprotein that contains selenium in the form of the amino acid selenocysteine. Like other selenoproteins, the role for SELENOF in carcinogenesis has been investigated due to its altered expression compared to the corresponding normal tissue, its molecular function, and the association of genetic variations in the gene to cancer risk or outcome. This review summarizes SELENOF's discovery, structure, cellular localization, and expression. SELENOF belongs to a new family of thioredoxin-like proteins. Published data summarized here indicate a likely role for SELENOF in redox protein quality control, and in the regulation of lipids, glucose, and energy metabolism. Current evidence indicates that loss of SELENOF contributes to the development of prostate and breast cancer, while its loss may be protective against colon cancer. Additional investigation into SELENOF's molecular mechanisms and its impact on cancer is warranted.
SELENOF,以前称为 SEP15,是一种含有硒代半胱氨酸形式的硒的硒蛋白。与其他硒蛋白一样,由于与相应的正常组织相比表达发生改变、其分子功能以及基因中的遗传变异与癌症风险或结果相关,SELENOF 在致癌作用中的作用已得到研究。这篇综述总结了 SELENOF 的发现、结构、细胞定位和表达。SELENOF 属于一种新的硫氧还蛋白样蛋白家族。这里总结的已发表数据表明,SELENOF 可能在氧化还原蛋白质量控制以及脂质、葡萄糖和能量代谢的调节中发挥作用。目前的证据表明,SELENOF 的缺失有助于前列腺癌和乳腺癌的发展,而其缺失可能对结肠癌具有保护作用。有必要对 SELENOF 的分子机制及其对癌症的影响进行进一步研究。